Post job

Fluidigm main competitors are Bill & Melinda Gates Foundation, Merck, and GasTechnology.

Competitor Summary. See how Fluidigm compares to its main competitors:

  • Merck has the most employees (74,000).
  • Employees at Bill & Melinda Gates Foundation earn more than most of the competitors, with an average yearly salary of $114,538.
Work at Fluidigm?
Share your experience

Fluidigm vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1999
4.6
South San Francisco, CA2$174.4M535
1935
4.8
Brea, CA1$3.7B12,000
1891
4.6
Kenilworth, NJ31$64.2B74,000
1988
4.9
Tarrytown, NY7$14.2B9,123
2002
4.8
Cambridge, MA2$2.2B1,323
2000
4.7
Seattle, WA2$4.8B1,602
-
4.5
Alexandria, VA1-1,700
1817
4.1
New York, NY1$24.4M785
1953
4.7
Chevy Chase, MD10$2.4B1,507
1978
4.7
Madison, WI2$450.0M1,601
National Inst for Pharmaceutical Tech & Ed
2005
3.8
Minneapolis, MN1$700,0003
1996
3.9
Addison, TX1$18.9M50
1985
3.9
Alexandria, VA1$8.5M150
1971
4.7
Houston, TX1$390.0M2,200
1941
4.7
Des Plaines, IL3$63.8M409
1994
3.6
Tampa, FL1$61.8M100
-
4.2
Humble, TX5$250.0M3,500
1971
4.7
Malvern, PA5$9.7B7,500
2018
4.4
Worthington, OH1$60.0M1,600
Life Science
-
4.0
Oakland, CA1$230,0006
TIAX
2002
3.4
Lexington, MA1$380,0007

Rate Fluidigm's competitiveness in the market.

Zippia waving zebra

Fluidigm salaries vs competitors

Among Fluidigm competitors, employees at Bill & Melinda Gates Foundation earn the most with an average yearly salary of $114,538.

Compare Fluidigm salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Fluidigm
$88,914$42.75-
Beckman Coulter
$77,445$37.23-
Merck
$90,328$43.43-
Regeneron
$85,589$41.15-
Alnylam Pharmaceuticals
$81,014$38.95-
Bill & Melinda Gates Foundation
$114,538$55.07-

Compare Fluidigm job title salaries vs competitors

CompanyHighest salaryHourly salary
Fluidigm
$77,391$37.21
Merck
$102,803$49.42
Regeneron
$102,587$49.32
Bill & Melinda Gates Foundation
$82,936$39.87
Beckman Coulter
$82,091$39.47
GasTechnology
$81,135$39.01
The New York Academy of Sciences
$78,586$37.78
Promega
$77,380$37.20
National Science Foundation
$75,941$36.51
National Inst for Pharmaceutical Tech & Ed
$73,002$35.10
Alnylam Pharmaceuticals
$69,760$33.54
Life Science
$68,162$32.77
Abs Consulting
$67,949$32.67
ERM
$66,615$32.03
Plexus Scientific
$66,425$31.94
Technology Transfer Services
$66,134$31.80
HHMI
$65,369$31.43
TIAX
$64,877$31.19
Hyperion Materials & Technologies
$63,751$30.65
EFI Global
$62,699$30.14

Do you work at Fluidigm?

Does Fluidigm effectively differentiate itself from competitors?

Fluidigm jobs

Fluidigm demographics vs competitors

Compare gender at Fluidigm vs competitors

Job titleMaleFemale
Alnylam Pharmaceuticals49%51%
Merck54%46%
Regeneron54%46%
ERM60%40%
Beckman Coulter64%36%
Fluidigm--
Male
Female
100%
75%
50%
25%
0%
0%
25%
50%
75%
100%

Compare race at Fluidigm vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
59%14%5%16%6%
9.1
56%16%10%14%4%
9.8
54%15%10%17%4%
9.8
54%21%8%13%4%
9.9
57%18%11%11%4%
9.7
51%14%13%18%5%
9.7

Fluidigm revenue vs competitors

Fluidigm revenue is $174.4M. Among it's competitors, the company with the highest revenue is Merck, $64.2B . The company with the lowest revenue is Life Science, $230.0K.

Fluidigm and similar companies CEOs

CEOBio
Yvonne L. Greenstreet
Alnylam Pharmaceuticals

Yvonne Greenstreet is a COO at ALNYLAM PHARMACEUTICALS, INC..

Robert M. Davis
Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Mark Errington
ERM

Dan E. Arvizu became the eighth Director of the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) on January 15, 2005. NREL, located in Golden, Colorado, is the Department of Energy's primary laboratory for energy efficiency and renewable energy research and development. NREL is operated for DOE by Alliance for Sustainable Energy, LLC (Alliance). He is President of Alliance and also is an Executive Vice President with MRIGlobal, headquartered in Kansas City, Missouri. Prior to joining NREL, Arvizu was the chief technology officer with CH2M HILL Companies, Ltd. Before joining CH2M he was an executive with Sandia National Laboratories in Albuquerque, New Mexico. He started his career and spent four years at the AT&T Bell Telephone Laboratories.

Jeff Jacobson
EFI Global

David Carroll
GasTechnology

Kevin McKenna
Authentix

Kevin McKenna is a President/CEO at Authentix and VP:Sales Americas at LaserCard Corporation. He has worked as Program Manager at INTERNATIONAL BUSINESS MACHINES CORP, Pres/Gen Mgr:Currency at Authentix, and Aviation Officer at United States Army. Kevin studied at West Point-United States Military Academy and Missouri University of Science and Technology.

CEO at Bill & Melinda Gates Foundation, impatient optimist, father, former journalist, and avid learner. He/Him/His.

Fluidigm competitors FAQs

Search for jobs